Patents by Inventor Jay A. Fishman

Jay A. Fishman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOLECULAR SEQUENCE OF SWINE RETROVIRUS AND METHODS OF USE
    Publication number: 20090162834
    Abstract: Purified nucleic acid which can specifically hybridize with the sequence of swine retroviruses.
    Type: Application
    Filed: December 15, 2008
    Publication date: June 25, 2009
    Applicant: The General Hospital Corporation
    Inventor: Jay A. Fishman
  • Molecular sequence of swine retrovirus and methods of use
    Patent number: 7465573
    Abstract: Purified nucleic acid which can specifically hybridize with the sequence of swine retroviruses.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: December 16, 2008
    Assignee: The General Hospital Corporation
    Inventor: Jay A. Fishman
  • Molecular sequence of swine retrovirus and methods of use
    Publication number: 20040185435
    Abstract: Purified nucleic acid which can specifically hybridize with the sequence of swine retroviruses.
    Type: Application
    Filed: November 26, 2003
    Publication date: September 23, 2004
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventor: Jay A. Fishman
  • Molecular sequence of swine retrovirus
    Patent number: 6699663
    Abstract: Purified nucleic acid which can specifically hybridize with the sequence of swine retroviruses.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: March 2, 2004
    Assignee: The General Hospital Corporation
    Inventor: Jay A. Fishman
  • Programmed cell death and Ich-3
    Publication number: 20030049709
    Abstract: This invention relates to modulation of programmed cell death. It also relates to transgenic non-human animals comprising a disrupted Ich-3 gene and methods of making these animals. The Ich-3 mutant animals exhibit resistance to septic shock and defects in folliculogenesis. This invention also relates to methods of using the transgenic animals to screen for compounds to treat septic shock and defective folliculogenesis. Moreover, this invention also relates to methods of treating septic shock in normal individuals by inhibiting ICH-3.
    Type: Application
    Filed: February 2, 2001
    Publication date: March 13, 2003
    Inventors: Junying Yuan, Suyue Wang, Masayuki Miura, Jay A. Fishman
  • Molecular sequences of swine retroviruses method of using
    Patent number: 6190861
    Abstract: Purified nucleic acid which can specifically hybridize with the sequence of swine retroviruses.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: February 20, 2001
    Assignee: The General Hospital Corporation
    Inventor: Jay A. Fishman
  • Molecular cloning of antigens shared by rat- and human-derived Pneumocystis carinii
    Patent number: 5442050
    Abstract: DNAs encoding antigens of mammalian, Pneumocystis carinii including the gp116 major surface antigen of rat and human P. carinii; P. carinii DNA containing homologous nucleotide sequences to the antigen encoding DNA; RNAs, proteins, monospecific antibodies and chimeric molecules derived from the DNAs; and probes and diagnostic methods, vaccine compositions and anti-P. carinii agents, and methods of treatment for and prophylaxis against P. carinii infection and pneumonitis are claimed.
    Type: Grant
    Filed: October 18, 1991
    Date of Patent: August 15, 1995
    Assignee: The General Hospital Corporation
    Inventor: Jay A. Fishman